Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275332
Max Phase: Preclinical
Molecular Formula: C14H21NO3
Molecular Weight: 251.33
Associated Items:
ID: ALA5275332
Max Phase: Preclinical
Molecular Formula: C14H21NO3
Molecular Weight: 251.33
Associated Items:
Canonical SMILES: Cc1cc(=O)c(O)c(CN2CC(C)CC(C)C2)o1
Standard InChI: InChI=1S/C14H21NO3/c1-9-4-10(2)7-15(6-9)8-13-14(17)12(16)5-11(3)18-13/h5,9-10,17H,4,6-8H2,1-3H3
Standard InChI Key: YIVMXVWQPWLGGP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 251.33 | Molecular Weight (Monoisotopic): 251.1521 | AlogP: 2.13 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.63 | CX Basic pKa: 7.72 | CX LogP: 1.84 | CX LogD: 1.46 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.87 | Np Likeness Score: 0.00 |
1. He M, Fan M, Peng Z, Wang G.. (2021) An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery., 221 [PMID:34023737] [10.1016/j.ejmech.2021.113546] |
Source(1):